EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor

E G W M Lentjes, M S Pratt iD, I P Kema, M van Faassen, R E A Musson, M J Vos iD

Endocrine Connections · 01.04.2026 · 15 (4)

DOI: 10.1530/ec-25-0805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 01.04.2026. Verfasst von E G W M Lentjes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Diagnostic Laboratory, Utrecht University Medical Center, Utrecht, The Netherlands. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite the universal calibration of commercial IGF1 immunoassays to WHO IS 02/254, substantial inter-assay variability persists, leading to inconsistent patient classification. Harmonization towards a higher-order analytical anchor may reduce such variability.

Methods

Four matrix-matched, multi-level serum reference materials (RMs) were prepared from donor serum and value-assigned using an LC-MS/MS method calibrated to WHO IS 02/254. Commutability was assessed according to IFCC recommendations across four immunoassays (Cobas, iSYS, Immulite, Liaison). Deming regression-based recalibration equations derived from commutable RMs were applied to patient samples and healthy donor samples. The primary quantitative endpoint was reduction in standard error of estimate (SEE) relative to the LC-MS/MS method. Age- and sex-specific LC-MS/MS-anchored reference intervals were constructed as a downstream application.

Results

Prior to recalibration, immunoassays showed positive bias relative to LC-MS/MS of up to 60%. All four RMs were commutable for Liaison and iSYS, whereas the lowest concentration RM was classified as non-commutable for Cobas and Immulite. Recalibration towards the LC-MS/MS anchor resulted in marked alignment towards the identity line and reduced pooled SEE from 7.82 to 4.89 nmol/L (−37.4%) in patient samples and from 7.34 to 2.09 nmol/L (−71.5%) in healthy samples. Although harmonization effects were assay-dependent at the individual platform level, overall cross-platform dispersion was substantially attenuated.

Conclusions

Matrix-matched, commutable serum RMs value-assigned by a higher-order LC-MS/MS procedure enable substantial reduction of inter-assay bias and variability among IGF1 immunoassays. Harmonization towards a higher-order analytical anchor is achievable in routine practice and provides a robust foundation for consistent cross-platform interpretation.

Schlagwörter

Stichwörter der Autor:innen

IGF1LC-MS/MSharmonizationreference intervals

Autor:innen und Institutionen

  • Central Diagnostic Laboratory, Utrecht University Medical Center, Utrecht, The Netherlands.
  • Foundation for Quality Assessment in Laboratory Medicine (SKML), Nijmegen, The Netherlands.
  • Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: M S Pratt, M J Vos

Zitieren

APA

Lentjes, E. G. W. M., Pratt, M. S., Kema, I. P., van Faassen, M., Musson, R. E. A., & Vos, M. J. (2026). Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor. Endocrine Connections, 15(4). https://doi.org/10.1530/ec-25-0805

Vancouver

Lentjes EGWM, Pratt MS, Kema IP, van Faassen M, Musson REA, Vos MJ. Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor. Endocrine Connections. 2026;15(4). doi:10.1530/ec-25-0805

BibTeX
@article{Lentjes2026,
  author = {Lentjes, E G W M and Pratt, M S and Kema, I P and van Faassen, M and Musson, R E A and Vos, M J},
  title = {Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor},
  journal = {Endocrine Connections},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1530/ec-25-0805}
}
Kostenlos starten →